FDA approves first interchangeable biosimilar insulin product for treatment of diabetes
The US FDA has approved the first interchangeable biosimilar insulin product, indicated to improve glycaemic control in adults and paediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus.